BioSpace News Archive

Business

Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer

Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express proteins inside the body for breakthrough treatments – today announced Pablo J. Cagnoni, M.D. as its Chief Executive Officer.

November 17, 2022
·
5 min read
Business

Marinus Pharmaceuticals Appoints CEO Scott Braunstein, M.D., as Chairman of the Board

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the Board of Directors has appointed Chief Executive Officer (CEO) and Board Director, Scott Braunstein, M.D., as Chairman of the Board.

November 17, 2022
·
7 min read
Biotech Beach

STAAR Surgical Opens EVO Experience Center in United States

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses for the eye, announced the opening of the first company-operated EVO Experience Center.

November 17, 2022
·
4 min read
BioCapital

The CorVista® Analysis Provides a Robust Prediction for Elevated Left Ventricular End Diastolic Pressure at the Point-Of-Care

The CorVista ® Analysis Provides a Robust Prediction for Elevated Left Ventricular End Diastolic Pressure at the Point-Of-Care.

November 17, 2022
·
4 min read
Drug Development

Ayala Pharmaceuticals Presents Poster on AL102 in Desmoid Tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting

Ayala Pharmaceuticals, Inc. today is announcing a poster presentation highlighting interim results from the Phase 2 segment / Part A of the RINGSIDE Pivotal Phase 2/3 clinical trial in desmoid tumors at the Connective Tissue Oncology Society Annual Meeting.

November 17, 2022
·
14 min read
Biotech Bay

Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million Series A to Advance Pipeline of Precision Therapeutics Based on Groundbreaking Integrated Disease Network Mapping Platform

Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, launched with $78 million from a Series A financing.

November 17, 2022
·
4 min read
Biotech Beach

JUNO DIAGNOSTICS™ ANNOUNCES LAUNCH OF JUNO HAZEL™, AN INNOVATIVE SOLUTION TO INCREASE ACCESSIBILITY AND AFFORDABILITY OF NON-INVASIVE PRENATAL SCREENING (NIPS)

Juno Diagnostics™ (JunoDx™), a company focused on bringing vital health information to patients by improving access, affordability, and transparency, today announced the launch of Juno Hazel™, a non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of blood.

November 17, 2022
·
3 min read
Business

Nanostics Announces New Member of Board of Directors

Nanostics Inc., a precision health diagnostics company, announced today the appointment of Aubrey Rankin to its Board of Directors.

November 17, 2022
·
2 min read
Biotech Beach

Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting

Aadi Bioscience, Inc. today presented three posters on completed and ongoing clinical trials for nab-sirolimus at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting, taking place November 16-19, 2022 in Vancouver, Canada.

November 17, 2022
·
7 min read
Thryv Therapeutics Inc. to Participate in 34th Piper Sandler Annual Healthcare Conference and in RBC Capital Markets Healthcare Private Company Virtual Conference

Thryv Therapeutics Inc. will participate in a fireside chat and host investor meetings at the upcoming 34th Piper Sandler Annual Healthcare Conference.

November 17, 2022
·
1 min read